Local pharmaceutical companies are gearing up to bid for a supplementary HIV/AIDS drug tender, which includes a large supply contract for a key drug previously awarded mostly to importers.

The new contract also has cost implications for the health department, which says it will have to find an additional R223m to fund an extra 45.1-million packs of the three-in-one pill combining tenofovir, emtricitabine and efavirenz, known as TEE...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.